Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome-positive acute lymphoblastic leukaemia (EsPhALL): a randomised, open-label, intergroup study - Biondi, A; Schrappe, M; De Lorenzo, P (Lancet Oncol, 2012)
et al.